221 related articles for article (PubMed ID: 37773193)
1. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study.
Ma C; Meng K; Shi S; Zhao T; Chen S; Zhou X; Shu R; Ma M; Tian M; Ding J
Eur J Med Res; 2023 Sep; 28(1):393. PubMed ID: 37773193
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
5. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases.
Lv C; Zhang Q; Tang P; Guo L; Ding Q
Adv Rheumatol; 2022 Oct; 62(1):37. PubMed ID: 36303230
[TBL] [Abstract][Full Text] [Related]
8. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cytokine interleukin 9 along with interleukin 4 and interferon γ in connective tissue disease-associated interstitial lung disease: association with severity of pulmonary fibrosis.
Jiang S; Wang Z; Ouyang H; Liu Z; Li L; Shi Y
Arch Med Sci; 2016 Feb; 12(1):101-6. PubMed ID: 26925124
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases.
Zhang Q; Guo L; Song X; Lv C; Tang P; Li Y; Ding Q; Li M
Clin Chim Acta; 2022 May; 530():8-12. PubMed ID: 35219714
[TBL] [Abstract][Full Text] [Related]
11. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients.
Tezcan D; Sivrikaya A; Ergün D; Özer H; Eryavuz Onmaz D; Körez MK; Akdağ T; Gülcemal S; Limon M; Yılmaz S
Clin Rheumatol; 2021 Nov; 40(11):4713-4724. PubMed ID: 34181129
[TBL] [Abstract][Full Text] [Related]
13. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
14. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
[No Abstract] [Full Text] [Related]
16. Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography.
Chen L; Zhu M; Lu H; Yang T; Li W; Zhang Y; Xie Q; Li Z; Wan H; Luo F
Respir Res; 2022 Mar; 23(1):47. PubMed ID: 35248040
[TBL] [Abstract][Full Text] [Related]
17. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
[TBL] [Abstract][Full Text] [Related]
18. An analysis of the clinical features of lung cancer in patients with connective tissue diseases.
Saijo A; Hanibuchi M; Goto H; Toyoda Y; Tezuka T; Nishioka Y
Respir Investig; 2017 Mar; 55(2):153-160. PubMed ID: 28274531
[TBL] [Abstract][Full Text] [Related]
19. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
20. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]